News and blogs
427 results found.
Genetic mutation 'likely cause' of childhood leukaemia
Blood Cancer UK-funded researchers say genetic mutation followed by infection is the most likely cause of the most common type of childhood leukaemia.
Blood cancer patients potentially losing access to crucial drugs
People with blood cancer risk being denied access to crucial treatments because of restrictions imposed by NHS England on the use of cancer medicines.
Three types of blood cancer treatment approved by NICE
NICE approves treatment for three types of blood cancer which will become routinely available on the NHS for people in England.
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS this year.
British Society for Haematology Annual Meeting 2018 highlights
I spent 3 days at the British Society for Haematology Annual Meeting in Liverpool with Blood Cancer UK research team. Read about some exciting studies.
MP Jess Phillips meets top leukaemia scientists
The Birmingham Yardley MP met Professor Paul Moss and his team at the Institute of Immunology and Immunotherapy before World AML Awareness Day.
Scientists granted over £500,000 to tackle acute myeloid leukaemia AML
Two research projects are underway at the University of Cambridge that are seeking to find new ways to treat acute myeloid leukaemia (AML).
A seat is so important when you have blood cancer
Why getting seat on the tube can be so important if you have blood cancer
Childhood leukaemia - scientists map the genetic evolution
Key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists in London.
Simon Thomas on his wife’s death from leukaemia
Sky Sports presenter Simon Thomas appeared on This Morning on 27 February to speak publicly for the first time about his wife’s sudden death from leukaemia.
Researchers work to treat chemotherapy-resistant leukaemia
Research shows treatment-resistance in aggressive blood cancer may be overcome by combining a new drug called venetoclax with chemotherapy.
All Party Parliamentary Group Meeting
A brief overview of the APPG event launching The 'Hidden' Cancer
NICE approves use of Gazyvaro for treatment of follicular lymphoma on NHS in England and Wales
NICE approves use of Gazyvaro for treatment of follicular lymphoma on NHS in England and Wales
Blood Cancer UK clinical trial on BBC
BBC documentary Find Me a Cure follows the experiences of patients and doctors involved in the Bloodwise-funded CLARITY clinical trial for over a year.
APPG launch blood cancer report
The All-Party Parliamentary Group (APPG) on blood cancer launched its first report on improving blood cancer care and MPs debated about NHS blood cancer care.
Latest statistics released on number of blood cancer cases in England
According to new figures from the Office for National Statistics, 303,135 people were diagnosed with cancer in England in 2016 – an increase of 3,212 people compared to the 2015 statistics.
APPG report on blood cancer care
The first report by the All Party Parliamentary Group (APPG) on blood cancer concludes that the government’s Cancer Strategy is not doing enough.
Coping with life after childhood cancer
Blogger Ed highlights some of the most difficult aspects of trying to live a normal life after cancer. Here he shares his experience.
How acute promyelocytic leukaemia develops
Our researchers carried out investigations into how acute promyelocytic leukaemia (APL) develops. Here's a breakdown of what they discovered.
How relevant are statistics?
Statistics are everywhere – especially when you have been diagnosed with blood cancer. Blogger Butterfly Anna explores whether or not they are important.